Skip to main content
TipRanks
Go Ultimate75% OFF

Kilian Kelly Insider Profile

4 Followers

Kilian Kelly, Director at Cynata Therapeutics Limited, holds 1.06M shares in Cynata Therapeutics Limited (Ticker: CYYNF). Most recently, Kilian Kelly Bought 265,703 shares of Cynata Therapeutics Limited on Nov 03, 2026 for an estimated value of $2.66K.

Kilian Kelly's Trading History

CYYNF
Cynata Therapeutics Limited
Nov 03, 2026DirectorInformative Buy2.66K$236.02K
CYYNF
Insider Shares: 1.06M (43.67%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Nov 03, 2026Informative BuyAU$2.66K265,703AU$0.01――
Jan 23, 2025Informative BuyAU$32.00K177,777AU$0.18+8.60%―
Nov 22, 2023Informative BuyAU$12.44K94,143AU$0.13+163.80%―

You May Also Like

Kilian Kelly insider profile FAQ

What is the percentage of profitable transactions made by Kilian Kelly?
The percentage of profitable transactions made by Kilian Kelly is 100%.
What is the average return per transaction made by Kilian Kelly?
The average return per transaction made by Kilian Kelly is 86.20%.
What stocks does Kilian Kelly hold?
Kilian Kelly holds: CYYNF stocks.
What was Kilian Kelly’s latest transaction?
Kilian Kelly’s latest transaction was an Informative Buy of $2.66K.
What was Kilian Kelly's most profitable transaction?
Kilian Kelly’s most profitable transaction was an Informative Buy of CYYNF stock on November 22, 2023. The return on the trade was 163.80%.
What is Kilian Kelly's role in Cynata Therapeutics Limited?
Kilian Kelly's role in Cynata Therapeutics Limited is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.